Calithera Biosciences Obtains $80,000,000 New Financing Round

  • Feed Type
  • Date
    10/2/2014
  • Company Name
    Calithera Biosciences
  • Mailing Address
    343 Oyster Point Blvd. South San Francisco, CA 94080 USA
  • Company Description
    The primary mission of Calithera Biosciences (NASDAQ: CALA) is to develop novel therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. Our first program is focused on developing activators of caspases, the proteases that induce apoptosis, for the treatment of cancer.
  • Website
    http://www.calithera.com
  • Transaction Type
    IPO
  • Transaction Amount
    $80,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms